Build a lasting personal brand

innoscripta Expands in Austria, Backlog Surpasses EUR 1 Million

By Advos
innoscripta SE has rapidly expanded into the Austrian market for R&D tax credits, acquiring over 30 customers and building a backlog exceeding EUR 1 million, highlighting the platform's cross-industry appeal.
innoscripta Expands in Austria, Backlog Surpasses EUR 1 Million

innoscripta SE (ISIN: DE000A40QVM8) is strengthening its presence in Austria, a market where it has operated since 2021. The company announced today that a dedicated team, established this year to focus on the Austrian R&D tax credit, has already secured more than 30 Austrian companies as customers. This has resulted in an order backlog exceeding EUR 1 million from concrete customer projects.

The Austrian R&D tax credit, available since 2002, offers a 14% tax credit on qualifying research and development expenditures. In 2024, Austrian companies applied for a total funding volume of EUR 1.4 billion. Notably, despite Austria's smaller economy, this figure surpasses the approximately EUR 1.2 billion paid out under Germany's R&D tax allowance in 2025. This indicates a robust market for R&D incentives in Austria, which innoscripta aims to serve with its software platform.

Sebastian Schwertlein, COO of innoscripta SE, commented, "Our rapid market success in Austria is further evidence of the competitiveness of our software-centric approach with the innovative Clusterix platform. We are particularly pleased to have attracted a broad range of new customers across different sectors, including industry and manufacturing, software and IT, logistics, and retail. This demonstrates that our approach works across industries."

The company's expansion into Austria is part of a broader international growth strategy, following market entries in France, the United Kingdom, and the United States. The Vienna office, established in 2021, previously focused on talent acquisition for the German business but now plays a central role in serving Austrian clients.

innoscripta SE offers Clusterix, a scalable software platform designed for the structured organization and management of research and development activities. The platform helps companies efficiently manage innovation projects, digitize internal processes, and make R&D activities transparent and scalable. By leveraging this technology, innoscripta aims to assist Austrian companies in navigating the complexities of R&D tax credits, ensuring they can maximize their eligible benefits.

The significance of this development lies in innoscripta's ability to replicate its success in Germany within a new market, demonstrating the platform's adaptability and the growing demand for digital R&D management solutions. For Austrian businesses, this means access to a proven tool that can streamline their R&D processes and potentially increase their tax credit claims. For the industry, it underscores the trend towards software-driven approaches in managing government incentives, which could lead to more efficient allocation of R&D funding across Europe.

As innoscripta continues its international expansion, the company is well-positioned to capitalize on the increasing digitization of R&D management. The strong initial uptake in Austria suggests that the market is ready for such solutions, and the company's order backlog provides a solid foundation for future growth in the region.

Advos

Advos

@advos